Cumberland Pharma Financials - Benzinga

Cumberland Pharmaceuticals Inc

CPIXNASDAQ

Trade with Public

Trade with Public

$8.97

0.273.1%

At close: Aug 26, 5:00 PM EST

$9.05

0.080.89%

After Hours: 4:01 PM EST

Overview News Earnings ForecastFinancialsSentiment Ownership Compare Options Stock Report

Cumberland Pharma Financials

Cumberland Pharma (CPIX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Cumberland Q2 Adj. EPS $(0.20) Down From $(0.13) YoY, Sales $166.458K Down From $380.797K YoY

Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.20) per share. This is a 53.85 percent decrease over losses of $(0.13) per share from the same period last year. The company reported $166.458 thousand in sales

Benzinga Newsdesk

PRO
Cumberland Q1 Adj. EPS $(0.13) Down From $0.16 YoY, Sales $9.131M Down From $11.713M YoY

Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.13) per share. This is a 181.25 percent decrease over earnings of $0.16 per share from the same period last year. The company reported $9.131 million in sales

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
Cumberland Q4 Adj. EPS $(0.01) Up From $(0.02) YoY, Sales $13.679M Up From $10.436M YoY

Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.01) per share. This is a 50 percent increase over losses of $(0.02) per share from the same period last year. The company reported $13.679 million in sales this

Benzinga Newsdesk

Earnings Scheduled For March 3, 2026

Benzinga Insights

PRO
Cumberland Q3 Adj. EPS $(0.06) Down From $(0.02) YoY, Sales $8.292M Down From $9.086M YoY

Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.06) per share. This is a 200 percent decrease over losses of $(0.02) per share from the same period last year. The company reported $8.292 million in sales this

Benzinga Newsdesk